𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The immune response of healthy adults to a reduced dose of hepatitis B vaccine

✍ Scribed by Wolf Szmuness; Cladd E. Stevens; Edward J. Harley; Edith A. Zang; Patricia E. Taylor; Harvey J. Alter; The Dialysis Vaccine Trial Group


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
592 KB
Volume
8
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Three hundred thirty‐six medical personnel from hemodialysis centers were treated with three doses, 20 ΞΌg each, of the Merck hepatitis B vaccine (at 0, 1, and 6 months). Within 1 month after the first injection, 41% converted to anti‐HBs positivity; after the second injection the conversion rate rose to 80–90%; and after the booster, to 96–98%. The later rate remained unchanged during the 18‐month follow‐up period. Only 2.8% of those vaccinated did not respond to the vaccine. The patterns of immune responses to 20‐μg doses were found to be exactly the same as to 40‐μg doses. It is suggested that reduced doses of vaccine should be as efficacious as the larger ones.


πŸ“œ SIMILAR VOLUMES


The immune response of healthy adults to
✍ Wolf Szmuness; Cladd E. Stevens; Edward J. Harley; Edith A. Zang; Patricia E. Ta πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 592 KB

## Abstract Immunologic markers associated with hepatitis B virus (HBV) infection (HBsAg, anti‐HBs, HBeAg, anti‐HBe, anti‐HBc, anti‐δ) were tested by radioimmunoassay of serum from chronic hepatitis patients. The corresponding liver biopsy samples were examined for the presence of HBsAg, HBcAg, and

The immune response of healthy nigerian
✍ E. A. Ayoola πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 174 KB

The immunogenic effect of hepatitis B vaccine (H-B-vax) was evaluated in 120 seronegative healthy Nigerians. Three doses of the vaccine were given at 0, 1, and 6 months. Serial blood samples were tested I month after each vaccination for hepatitis B surface antibody (anti-HBs) and antibody to hepati

Immune responses to late booster doses o
✍ Dr. Wolfgang Jilg; Marion Schmidt; Friedrich Deinhardt πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 295 KB πŸ‘ 1 views

Nineteen healthy young adults were vaccinated with plasma-derived hepatitis B vaccine at months 0, 1, and 12, and their immune responses were compared to those of a similar group of 20 vaccinees immunized at months 0, 1, and 6. Late booster injections at 12 months produced nearly fivefold higher geo

Reduced doses of hepatitis B immune glob
✍ Tsang-Ming Ko; Fon-Jou Hsieh; Chih-Liang Yaung; Prof. Ding-Shinn Chen; Kai-Hsin πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 468 KB

newborn infants of 79 hepatitis B surface antigen (HBsAg)-positive women were enrolled in a study of the efficacy of hepatitis B immune globulin (HBIG) in the prophylaxis of perinatal transmission of hepatitis B virus (HBV) infection. HBIG 0.5 ml or 0.25 ml was given to the newborn within 15 minutes